Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
Farmers Insurance
US Army
QuintilesIMS
Cipla
Colorcon
AstraZeneca
McKesson

Generated: August 20, 2018

DrugPatentWatch Database Preview

PRAVACHOL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Pravachol, and what generic alternatives are available?

Pravachol is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in PRAVACHOL is pravastatin sodium. There are sixteen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.

Drug patent expirations by year for PRAVACHOL
Pharmacology for PRAVACHOL
Medical Subject Heading (MeSH) Categories for PRAVACHOL
Synonyms for PRAVACHOL
(?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
(|AR, |AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A, |A,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic acid sodium hydrate
(|AR,|AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A,|A,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Sodium Salt
(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na
1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-
115873-26-2
3-beta-Hydroxycompactin sodium salt
3beta-Hydroxycompactin, Na
3M8608UQ61
81093-37-0 (Parent)
81131-70-6
81131-73-9
85956-24-7
87098-76-8
AK150793
AKOS015896504
AKOS015964902
Aplactin
Bio-0081
Bristacol
C-22432
C23H35NaO7
C23H35O7.Na
CAS-81131-70-6
CC-33901
CCG-100926
CHEBI:8361
CHEMBL690
CPD000469187
CRES Pravastatin
CS-2003
CS-514
D00893
DRG-0319
DSSTox_CID_27525
DSSTox_GSID_47525
DSSTox_RID_82395
DTXSID6047525
Elisor
Epastatin sodium
Eptastatin sodium
Eptastatin sodium salt hydrate
HMS2051P05
HMS3268L20
HY-B0165A
I06-2463
Kopostat
Lipemol
Lipidal
Liplat
Lipostat
Liprevil
LS-94711
Mevalotin
MFCD00887601
MolPort-003-849-962
NC00176
NCGC00092370-01
NCGC00095183-01
NCGC00254232-01
P1796
Pralidon
Prareduct
Pravachol (TN)
Pravacol
Pravaselect
Pravasin
Pravasine
Pravastatin (sodium)
Pravastatin Natrium Mayrho Fer
PRAVASTATIN SODIUM
Pravastatin sodium (JP17/USAN)
Pravastatin sodium [USAN:JAN]
Pravastatin sodium [USAN:USP:JAN]
Pravastatin Sodium Salt
Pravastatin sodium salt hydrate
Pravastatin sodium salt hydrate, >=98% (HPLC), powder
Pravastatin, Sodium Salt
PubChem21972
s3036
SAM001246656
Sanaprav
SC-46788
SCHEMBL3013
Selektine
Selipran
Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
SQ 31000
SQ-31000
ST2407537
Tox21_111474
Tox21_300270
UNII-3M8608UQ61
Vasen
VWBQYTRBTXKKOG-IYNICTALSA-M

US Patents and Regulatory Information for PRAVACHOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-002 Oct 31, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-008 Dec 18, 2001 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-003 Oct 31, 1991 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-004 Mar 22, 1993 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for PRAVACHOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-004 Mar 22, 1993 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-008 Dec 18, 2001 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-003 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-004 Mar 22, 1993 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-002 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for PRAVACHOL
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 30 mg ➤ Subscribe ➤ Sign Up

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Fuji
Chubb
US Department of Justice
Teva
UBS
Merck
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.